Product Information
MICARDIS 40 MG TABLET is a brand product labeled by Boehringer Ingelheim Pharmaceuticals Inc., priced at $4.5019 per EA under NDC 00597004037. Its NADAC has been published 519 times since Nov 28, 2013.
FDA first approved this application on Nov 10, 1998. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the telmisartan market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
40 mg/1
Manufacturer
Boehringer Ingelheim Pharmaceuticals Inc.NDC
00597004037
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
12/17/2025
Active Ingredients
TELMISARTANApproval Type
New Drug (NDA)
FDA Application
NDA020850FDA Approved
11/10/1998
TE Code
AB
On Market Since
12/1/2000
Pharmacological Classes
Price Statistics
The NADAC for MICARDIS 40 MG TABLET has been published 519 times since Nov 28, 2013, and over the history we have for it it has risen 2.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.5019 per EA |
|---|---|
| All-time high | $6.9320 (Aug 14, 2019) |
| All-time low | $4.3187 (Dec 18, 2013) |
| 52-week high | $4.5019 |
| 52-week low | $4.4951 |
| Median price | $5.6916 |
| Average price | $5.6859 |
| Largest weekly change | -35.0% (Apr 17, 2024) |
| Weeks tracked | 519 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
0.0%
6M
0.0%
1Y
+0.2%
3Y
-34.8%
5Y
-34.8%
All
+2.7%
Last surveyed Jul 1, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 97% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MICARDIS 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MICARDIS 40 MG TABLET, manufactured by Boehringer Ingelheim Pharmaceuticals Inc., is $4.5019 per EA (NDC 00597004037), effective Jul 1, 2026.
How has the price of MICARDIS 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for MICARDIS 40 MG TABLET has risen 2.7%. It has been tracked across 519 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MICARDIS 40 MG TABLET?
Since Nov 28, 2013, the NADAC for MICARDIS 40 MG TABLET has ranged from a low of $4.3187 (Dec 18, 2013) to a high of $6.9320 (Aug 14, 2019), with a median of $5.6916 per EA.
Are there cheaper alternatives to MICARDIS 40 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TELMISARTAN 40 MG TABLET, is $0.1536 per EA — about 97% below MICARDIS 40 MG TABLET.
Who manufactures MICARDIS 40 MG TABLET?
MICARDIS 40 MG TABLET (NDC 00597004037) is labeled by Boehringer Ingelheim Pharmaceuticals Inc., and CMS classifies it as a brand product.